Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma

Cancer Res (2020) 80 (20): 4335–4345.

https://doi.org/10.1158/0008-5472.CAN-20-0521

Published: 15 October 2020

View articletitled, Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma

Includes: Supplementary data

Journal Articles

Abstract CT036: Targeting MUC16 with the THIOMAB^TM-drug conjugate DMUC4064A in patients with platinum-resistant ovarian cancer: A phase I expansion study

Kathleen Moore, Erica P. Hamilton, Howard A. Burris, Lisa M. Barroilhet, Martin Gutierrez, Judy S. Wang, Manish R. Patel, Michael J. Birrer, W. Mike Flanagan, Yulei Wang, Amit Garg, Xuyang Lu, Anjali Vaze, Dilip Amin, Douglas Leipold, S. Renee Commerford, Eric W. Humke, Joyce F. Liu

Cancer Res (2018) 78 (13_Supplement): CT036.

https://doi.org/10.1158/1538-7445.AM2018-CT036

Published: 01 July 2018

View articletitled, Abstract CT036: Targeting MUC16 with the THIOMABTM-drug conjugate DMUC4064A in patients with platinum-resistant ovarian cancer: A phase I expansion study

Journal Articles

Abstract LB-214: The immunosuppressive roles of ovarian stromal tumor microenvironment

Tsz-Lun Yeung, Cecilia S. Leung, Kwong-Kwok Wong, Michael J. Birrer, Stephen T. Wong, Karen H. Lu, Samuel C. Mok

Cancer Res (2017) 77 (13_Supplement): LB-214.

https://doi.org/10.1158/1538-7445.AM2017-LB-214

Published: 01 July 2017

View articletitled, Abstract LB-214: The immunosuppressive roles of ovarian stromal tumor microenvironment

Journal Articles

Abstract CT009: Targeting MUC16 with the THIOMAB^TM-drug conjugate DMUC4064A in patients with platinum-resistant ovarian cancer: a Phase I escalation study

Joyce F. Liu, Kathleen N. Moore, Judy S. Wang, Manish Patel, Michael J. Birrer, Erika Hamilton, Lisa Barroilhet, William M. Flanagan, Yulei Wang, Amit Garg, Xuyang Lu, Anjali Vaze, Dilip Amin, Doug Leipold, S Renee Commerford, Eric W. Humke, Harold A. Burris

Cancer Res (2017) 77 (13_Supplement): CT009.

https://doi.org/10.1158/1538-7445.AM2017-CT009

Published: 01 July 2017

View articletitled, Abstract CT009: Targeting MUC16 with the THIOMABTM-drug conjugate DMUC4064A in patients with platinum-resistant ovarian cancer: a Phase I escalation study

Journal Articles

Abstract 4196: Real-time single-walled nanotube (SWNT)-based imaging system improves tumor detection and survival in ovarian cancer animal model

Lorenzo Ceppi, YoungJeong Na, Neelkanth M. Bardhan, Andrew Siegel, Nandini Rajan, Angela M. Belcher, Michael J. Birrer

Cancer Res (2016) 76 (14_Supplement): 4196.

https://doi.org/10.1158/1538-7445.AM2016-4196

Published: 15 July 2016

View articletitled, Abstract 4196: Real-time single-walled nanotube (SWNT)-based imaging system improves tumor detection and survival in ovarian cancer animal model

Journal Articles

Abstract 1102: Integrated genomic analysis of clear-cell ovarian cancer identifies PRKCI as a therapeutic target

Tsun Yee Tsang, Gayatry Mohapatra, Hiroaki Itamochi, Samuel C. Mok, Michael J. Birrer

Cancer Res (2015) 75 (15_Supplement): 1102.

https://doi.org/10.1158/1538-7445.AM2015-1102

Published: 01 August 2015

View articletitled, Abstract 1102: Integrated genomic analysis of clear-cell ovarian cancer identifies PRKCI as a therapeutic target

Journal Articles

Abstract 4184: CAF-derived MFAP5 promotes tumor angiogenesis and confers paclitaxel resistance in high-grade serous ovarian cancer

Cecilia S. Leung, Tsz-Lun Yeung, Kay-Pong Yip, Kwong-Kwok Wong, Anil K. Sood, Michael J. Birrer, Samuel C. Mok

Cancer Res (2015) 75 (15_Supplement): 4184.

https://doi.org/10.1158/1538-7445.AM2015-4184

Published: 01 August 2015

View articletitled, Abstract 4184: CAF-derived MFAP5 promotes tumor angiogenesis and confers paclitaxel resistance in high-grade serous ovarian cancer

Journal Articles

Abstract 5401: TGF-β signaling inhibition as a potential approach to target suboptimally debulked ovarian tumors

Wei Wei, Michael J. Birrer

Cancer Res (2015) 75 (15_Supplement): 5401.

https://doi.org/10.1158/1538-7445.AM2015-5401

Published: 01 August 2015

View articletitled, Abstract 5401: TGF-β signaling inhibition as a potential approach to target suboptimally debulked ovarian tumors

Journal Articles

Abstract 1029: CAF-derived MFAP5 promotes ovarian tumor angiogenesis through calcium dependent LPP signaling pathway

Cecilia S. Leung, Tsz-Lun Yeung, Kay-Pong Yip, Kwong-Kwok Wong, Anil K. Sood, Michael J. Birrer, Samuel C. Mok

Cancer Res (2014) 74 (19_Supplement): 1029.

https://doi.org/10.1158/1538-7445.AM2014-1029

Published: 01 October 2014

View articletitled, Abstract 1029: CAF-derived MFAP5 promotes ovarian tumor angiogenesis through calcium dependent LPP signaling pathway

Journal Articles

Abstract 1528: Identification of FGFR3 as a potential therapeutic target gene for human clear cell ovarian cancer by global genomic analysis

Tsun Yee Tsang, Gayatry Mohapatra, Hiroaki Itamochi, Samuel C. Mok, Michael J. Birrer

Cancer Res (2014) 74 (19_Supplement): 1528.

https://doi.org/10.1158/1538-7445.AM2014-1528

Published: 01 October 2014

View articletitled, Abstract 1528: Identification of FGFR3 as a potential therapeutic target gene for human clear cell ovarian cancer by global genomic analysis

Journal Articles

Abstract 2056: Identification of microscopic ovarian tumor foci utilizing a novel imaging device in a murine ovarian cancer model, an opportunity to improve optimal cytoreduction

Youngjeong Na, Tim Kwok, Christopher Awtrey, David B. Strasfeld, Jorge M. Ferrer, David Lee, Michael J. Birrer

Cancer Res (2014) 74 (19_Supplement): 2056.

https://doi.org/10.1158/1538-7445.AM2014-2056

Published: 01 October 2014

View articletitled, Abstract 2056: Identification of microscopic ovarian tumor foci utilizing a novel imaging device in a murine ovarian cancer model, an opportunity to improve optimal cytoreduction

Journal Articles

TGF-β Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment

Tsz-Lun Yeung, Cecilia S. Leung, Kwong-Kwok Wong, Goli Samimi, Melissa S. Thompson, Jinsong Liu, Tarrik M. Zaid, Sue Ghosh, Michael J. Birrer, Samuel C. Mok

Cancer Res (2013) 73 (16): 5016–5028.

https://doi.org/10.1158/0008-5472.CAN-13-0023

Published: 13 August 2013

View articletitled, TGF-β Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment

Includes: Supplementary data

Journal Articles

Abstract 799: Global genomic analysis identified PRKCI as a potential therapeutic target gene for human clear cell ovarian cancer.

Tsun Yee Tsang, Gayatry Mohapatra, Hiroaki Itamochi, Samuel C. Mok, Michael J. Birrer

Cancer Res (2013) 73 (8_Supplement): 799.

https://doi.org/10.1158/1538-7445.AM2013-799

Published: 15 April 2013

View articletitled, Abstract 799: Global genomic analysis identified PRKCI as a potential therapeutic target gene for human clear cell ovarian cancer.

Journal Articles

Abstract 2997: SOX2 contributes towards invasive phenotype of serous ovarian cancer by up-regulating MMP2.

Gayatry Mohapatra, Junko Kikuchi, Michael J. Birrer

Cancer Res (2013) 73 (8_Supplement): 2997.

https://doi.org/10.1158/1538-7445.AM2013-2997

Published: 15 April 2013

View articletitled, Abstract 2997: SOX2 contributes towards invasive phenotype of serous ovarian cancer by up-regulating MMP2.

Journal Articles

Abstract 4579: Variants in long non-coding RNAs are associated with epithelial ovarian cancer risk in a pooled analysis of three genome-wide association studies.

Yian Ann Chen, Zhihua Chen, Jennifer Permuth-Wey, Ya-Yu Tsai, Hui-Yi Lin, Xiaotao Qu, Kate Lawrenson, David Fenstermacher, Catherine M. Phelan, Alvaro Monteiro, Simon A. Gayther, Steven A. Narod, Rebecca Sutphen, Michael J. Birrer, Nicolas Wentzensen, Joellen M. Schildkraut, Ellen L. Goode, Paul Pharoah, Thomas Sellers

Cancer Res (2013) 73 (8_Supplement): 4579.

https://doi.org/10.1158/1538-7445.AM2013-4579

Published: 15 April 2013

View articletitled, Abstract 4579: Variants in long non-coding RNAs are associated with epithelial ovarian cancer risk in a pooled analysis of three genome-wide association studies.

Journal Articles

Abstract 5057: Gene expression profile of chemoresponse of microdissected papillary serous tumors of the ovary identifies POLH and REV3L as potential therapeutic targets

Vinod Vathipadiekal, Laurent Ozbun, Jeong-Won Lee, Pablo Vivas-Mejia, Gabriel Lopez-Berestein, Anil K. Sood, Samuel C. Mok, Michael J. Birrer

Cancer Res (2012) 72 (8_Supplement): 5057.

https://doi.org/10.1158/1538-7445.AM2012-5057

Published: 15 April 2012

View articletitled, Abstract 5057: Gene expression profile of chemoresponse of microdissected papillary serous tumors of the ovary identifies POLH and REV3L as potential therapeutic targets

Journal Articles

Abstract 2603: Subtype-specific ovarian cancer risk associated with SNPs in IL1A

Cancer Res (2012) 72 (8_Supplement): 2603.

https://doi.org/10.1158/1538-7445.AM2012-2603

Published: 15 April 2012

View articletitled, Abstract 2603: Subtype-specific ovarian cancer risk associated with SNPs in IL1A

Journal Articles

Abstract 1507: TGF-beta induced stromal versican promotes cancer invasion in advanced stage serous ovarian cancer

Tsz-Lun Yeung, Cecilia Leung, Sue Ghosh, Jinsong Liu, Kwong-Kwok Wong, Michael J Birrer, Samuel C Mok

Cancer Res (2012) 72 (8_Supplement): 1507.

https://doi.org/10.1158/1538-7445.AM2012-1507

Published: 15 April 2012

View articletitled, Abstract 1507: TGF-beta induced stromal versican promotes cancer invasion in advanced stage serous ovarian cancer

Journal Articles

Abstract 4270: Novel stromal angiogenic factor MFAP5 in ovarian cancer progression

Sze Lee Cecilia Leung, Tsz-Lun Yeung, Lavanya Balasubramanian, Kay-Pong Yip, Jinsong Liu, Kwong-Kwok Wong, Anil K. Sood, Michael J. Birrer, Samuel C. Mok

Cancer Res (2012) 72 (8_Supplement): 4270.

https://doi.org/10.1158/1538-7445.AM2012-4270

Published: 15 April 2012

View articletitled, Abstract 4270: Novel stromal angiogenic factor MFAP5 in ovarian cancer progression

Journal Articles

Abstract 1072: The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer

Wei Wei, Gayatry Mohapatra, Michael J. Birrer

Cancer Res (2012) 72 (8_Supplement): 1072.

https://doi.org/10.1158/1538-7445.AM2012-1072

Published: 15 April 2012

View articletitled, Abstract 1072: The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma

Abstract CT036: Targeting MUC16 with the THIOMAB^TM-drug conjugate DMUC4064A in patients with platinum-resistant ovarian cancer: A phase I expansion study

Abstract LB-214: The immunosuppressive roles of ovarian stromal tumor microenvironment

Abstract CT009: Targeting MUC16 with the THIOMAB^TM-drug conjugate DMUC4064A in patients with platinum-resistant ovarian cancer: a Phase I escalation study

Abstract 4196: Real-time single-walled nanotube (SWNT)-based imaging system improves tumor detection and survival in ovarian cancer animal model

Abstract 1102: Integrated genomic analysis of clear-cell ovarian cancer identifies PRKCI as a therapeutic target

Abstract 4184: CAF-derived MFAP5 promotes tumor angiogenesis and confers paclitaxel resistance in high-grade serous ovarian cancer

Abstract 5401: TGF-β signaling inhibition as a potential approach to target suboptimally debulked ovarian tumors

Abstract 1029: CAF-derived MFAP5 promotes ovarian tumor angiogenesis through calcium dependent LPP signaling pathway

Abstract 1528: Identification of FGFR3 as a potential therapeutic target gene for human clear cell ovarian cancer by global genomic analysis

Abstract 2056: Identification of microscopic ovarian tumor foci utilizing a novel imaging device in a murine ovarian cancer model, an opportunity to improve optimal cytoreduction

TGF-β Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment

Abstract 799: Global genomic analysis identified PRKCI as a potential therapeutic target gene for human clear cell ovarian cancer.

Abstract 2997: SOX2 contributes towards invasive phenotype of serous ovarian cancer by up-regulating MMP2.

Abstract 4579: Variants in long non-coding RNAs are associated with epithelial ovarian cancer risk in a pooled analysis of three genome-wide association studies.

Abstract 5057: Gene expression profile of chemoresponse of microdissected papillary serous tumors of the ovary identifies POLH and REV3L as potential therapeutic targets

Abstract 2603: Subtype-specific ovarian cancer risk associated with SNPs in IL1A

Abstract 1507: TGF-beta induced stromal versican promotes cancer invasion in advanced stage serous ovarian cancer

Abstract 4270: Novel stromal angiogenic factor MFAP5 in ovarian cancer progression

Abstract 1072: The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only